BIOTECH
Governance-native AI infrastructure for biopharm R&D, cell and gene therapy developers, and contract research
Constitutional RuntimeWho this is for
Biopharmaceutical research and translational teams, cell and gene therapy developers, biologics manufacturers, contract research and contract development organizations, and preclinical and clinical operations groups deploying AI where a wrong answer touches an experimental record, a batch history, a protocol amendment, or a regulatory submission. ETHRAEON provides constitutional runtime posture. Sponsor and site regulatory responsibility remains with the organization operating the study.
- Biopharm R&D and translational science organizations
- Cell and gene therapy developers and process-development teams
- Contract research organizations and contract development and manufacturing organizations
- Preclinical, clinical operations, and regulatory affairs teams
- Biobank, biorepository, and specimen-tracking operations
Capability surface
Constitutional runtime
The PRAXIS 7-Gate pipeline enforces governance on every AI action. It stops when unsure. Evidence is mandatory. Defaults deny rather than guess. Experimental reasoning, protocol drafting, and batch-history workflows inherit this posture by construction, not by policy overlay.
Experimental and batch evidence
Every AI action against an experimental record, electronic lab notebook entry, batch history, or process-development artifact records to a tamper-evident, SHA-256 hash-chained evidence store. Sponsor audit, regulatory inspection, and internal review trace by default.
Protocol and submission integrity
AI-assisted protocol drafting, amendment reasoning, and regulatory-submission synthesis carry sealed provenance for source data, version state, and human authority. Deterministic guardrails prevent silent scope drift on regulated documentation.
Pharmacovigilance and safety posture
Case intake, signal detection, narrative drafting, and periodic-report synthesis pass through the runtime with provenance and human-authority checkpoints preserved. Safety signals carry the sealed chain from source report to reviewed disposition.
Reagent and chain-of-custody provenance
Reagent qualification, chain-of-custody records, cold-chain excursion signals, and specimen provenance carry the same evidence chain as the AI actions that reason over them. Sponsor and site operations reach one authoritative record.
Sovereign deployment
On-premise, private-cloud, or hybrid sovereign deployment for sponsors and manufacturers that cannot expose sequence data, patient-derived material metadata, or process IP to a vendor cloud. Evidence store and constitutional runtime run inside the boundary you already validate.
Where governance meets the research and translational lifecycle
Biotech and translational organizations compound risk when AI is retrofitted onto research, quality, and pharmacovigilance surfaces. ETHRAEON is designed for the classes of decision where scientific integrity, sponsor obligation, and audit trail all matter.
- Research and translational reasoning. AI-assisted literature synthesis, target-and-mechanism reasoning, and experimental-design drafting carry sealed provenance: input tags, model version, guardrail state, and human authority for edge-case escalation.
- Process development and batch review. Batch-history reasoning, deviation triage, and process-development synthesis pass through the constitutional runtime with quality posture enforced by construction.
- Clinical operations and safety review. Case narrative drafting, adverse-event aggregation, and periodic-report synthesis record the reasoning chain from source report to reviewed disposition.
- Regulatory submission assembly. Module drafting, cross-reference reconciliation, and version-anchored submission assembly carry hash-chained provenance from source dataset to filed artifact.
Mapped ETHRAEON products
The operational problem in biotech is proving, under GxP and 21 CFR Part 11, that an experimental-record or submission determination was governed: obligations identified, mapped to policy and control, approved by a named authority, and replayable from pinned source data. Three ETHRAEON products map directly onto that problem and run as one governed workflow. The concrete deliverable is a claims-evidence receipt plus a GxP and 21 CFR Part 11 approval-and-attestation trail.
Compliance Engine
Live runtime, available by subscription. For a developer it captures the GxP, GCP, and 21 CFR Part 11 obligations that bind an electronic-lab-notebook, batch-history, or submission-synthesis action and maps each to the quality system. It records the obligation, the obligation-to-policy-to-control mapping, and each evidence linkage through the governed runtime; every evidence linkage returns a SHA-256 evidence node. It runs EU AI Act risk-class detection, GDPR data-lineage tracing, cross-border data-movement flags with provenance, and configurable rule packs per jurisdiction, and exports a regulator-ready audit log. It never issues, claims, or implies certification; sign-off remains a human authority act.
Governance Dashboard
Live runtime, available by subscription. For the quality and regulatory function it surfaces live enforcement state across experimental-record and submission workflows for sponsor-audit and inspection readiness. It is the composition and observability layer over the governed-decision products: a live constitutional-rule enforcement panel, per-model and per-agent policy-state visibility, a preventative halt log with rationale, per-tenant rule scoping, and a read-only board or audit-committee view, white-label on request. It reads governed-runtime state and never overrides a constitutional or authority boundary.
GENTHOS 3.0
Refinement, quality-assurance, and governance-safe output engine. For the protocol or submission claim it refines and quality-assures the governance-safe artifact with sealed provenance for source data and version state; it never sets the scientific conclusion. It executes only after upstream routing, within constitutional bounds, and writes each refinement step to the append-only evidence chain. It never performs the sovereign decision, the valuation, or the arbitration; SOC 2 is self-certified and ISO 42001 and EU AI Act alignment are readiness-mapped, not certified.
Deliverable: a claims-evidence receipt plus a GxP and 21 CFR Part 11 approval-and-attestation trail for a protocol, amendment, or submission-synthesis action. It maps against GxP, GCP, and 21 CFR Part 11 audit-trail expectations, and it is produced by the governed runtime at the moment of the action, not reconstructed under review pressure afterward.
The scientific and regulatory conclusion stays with the qualified investigator; the runtime produces and governs the evidence.
Proof surface
ETHRAEON runs its own operations under constitutional governance. 300 plus production surfaces, 700 plus governance directives executed and evidenced, a hash-chained evidence store, and a substrate registry that reports live status. The infrastructure is the demonstration.
Engagement
Biotech engagements start with a governance briefing scoped to your research and development portfolio, quality posture, and current AI deployment surface. The briefing produces a written architecture assessment and a deployment path proposal. From there: pilot inside a validated environment, evidenced production integration, or sovereign private-cloud install.
Portfolio anchors
ETHRAEON is a constitutional runtime and evidence control layer. Portfolio posture: 16 filed U.S. provisional applications / 75 technical specifications / 9 families. Public claims are calibrated. AGI-class and ASI-class positioning is architectural, not an achievement claim. This surface describes commercial capability posture. It is not a representation of clinical outcome, regulatory approval, or intended therapeutic use for any specific product. Sponsors and manufacturers retain full responsibility for regulatory compliance of their own programs.